SCHEMBL1129741

SCHEMBL1129741

O=C(O)CC(C(=O)O)(S(=O)(=O)O)S(=O)(=O)O

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.42
CYP2D6 P10635 1/20 0.40
TSHR P16473 1/20 0.40
CYP2C19 P33261 1/20 0.40
HIF1A Q16665 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
HMGCR P04035 1/20 0.36
CHRM1 P11229 1/20 0.36
TBXA2R P21731 1/20 0.36
ADRA1A P35348 1/20 0.36
ACLY P53396 3/20 0.34
CPT2 P23786 2/20 0.33
POLB P06746 1/20 0.33
KDM4E B2RXH2 1/20 0.31
FFAR1 O14842 1/20 0.31
TDP1 Q9NUW8 1/20 0.31
APEX1 P27695 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2521500 0.97 ALDH1A1 (0.40) ALDH1A1CYP2D6TSHRCYP2C19HIF1A
Ammonia Solution, Strong SCHEMBL11776041 0.97 ALDH1A1 (0.40) ALDH1A1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL28489478 0.97 ALDH1A1 (0.40) ALDH1A1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL10887081 0.86 ALDH1A1 (0.36) ALDH1A1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL6634867 0.74 ALDH1A1 (0.40) ALDH1A1L3MBTL1
SCHEMBL6561842 0.74 ALDH1A1 (0.42) ALDH1A1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL6570219 0.72 ALDH1A1 (0.46) ALDH1A1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL17760613 0.72 LMNA (0.42) ALDH1A1CYP2D6TSHRL3MBTL1ADRA1A
SCHEMBL18798923 0.72 ACLY (0.38) ALDH1A1CYP2D6TSHRCYP2C19HIF1A
SCHEMBL6935497 0.70 ALDH1A1 (0.39) ALDH1A1CYP2D6TSHRCYP2C19HIF1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 589 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12624277-B2 Injection fluids for stimulating fractured formations CHEVRON U.S.A. INC. (US) 2026-05-12 US claimed
US-20260098204-A1 INJECTION FLUIDS COMPRISING AN ANIONIC SURFACTANT FOR TREATING UNCONVENTIONAL FORMATIONS CHEVRON USA INC (US) 2026-04-09 US claimed
US-20260055314-A1 POLYANIONIC SURFACTANTS AND METHODS OF MAKING AND USING THEREOF CHEVRON USA INC (US) 2026-02-26 US claimed
US-20250354063-A1 POLYANIONIC SURFACTANTS AND METHODS OF MAKING AND USING THEREOF CHEVRON USA INC (US) 2025-11-20 US claimed
US-12435262-B2 Injection fluids comprising an anionic surfactant for treating unconventional formations CHEVRON U.S.A. INC. (US) 2025-10-07 US claimed
US-12331245-B2 Use of a borate-acid buffer in oil and gas operations CHEVRON U.S.A. INC. (US) 2025-06-17 US claimed
US-12286588-B2 Polyanionic surfactants and methods of making and using thereof CHEVRON U.S.A. INC. (US) 2025-04-29 US claimed
US-20240327698-A1 INJECTION FLUIDS FOR STIMULATING FRACTURED FORMATIONS CHEVRON U.S.A. INC. 2024-10-03 US claimed
CN-115768852-B Polyanionic surfactants and methods of making and using the same 雪佛龙美国公司 2024-08-23 CN claimed
US-20240279532-A1 INJECTION FLUIDS COMPRISING A NON-IONIC SURFACTANT FOR TREATING UNCONVENTIONAL FORMATIONS CHEVRON U.S.A. INC. 2024-08-22 US claimed
EP-0559472-B1 Low-foaming, liquid cleaning compositions UNILEVER PLC (GB) 1996-05-15 EP claimed
WO-1993002176-A1 METHOD OF PRODUCING HIGH-BULK-DENSITY WASHING AGENTS WITH IMPROVED DISSOLVING SPEED HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1993-02-04 WO claimed
EP-0103696-B1 AQUEOUS SURFACTANT CONCENTRATES AND PROCESS FOR THE FLOW BEHAVIOUR OF VISCOUS AQUEOUS SURFACTANT CONCENTRATES Henkel Kommanditgesellschaft auf Aktien (DE) 1989-04-12 EP claimed
EP-0121184-B1 USE OF BIS-SEMI-ESTERS OF SULFOSUCCINIC ACID WITH POLYETHER DIOLS BASED ON ETHYLENE/PROPYLENE OXIDE OR THEIR SALTS AS POLYMERISATION EMULGATORS Henkel Kommanditgesellschaft auf Aktien (DE) 1987-05-13 EP claimed
US-4540778-A Sulfosuccinate, alkyl- and alkenyl sulfosuccinate, sulfomaleate, and disulfosuccinate half-esters of polygalactomannans NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1985-09-10 US claimed
US-4540807-A SURFACTANTS FOR EMULSION POLYMERIZATION WITCO CHEMICAL CORPORATION (US) 1985-09-10 US claimed
US-4473489-A ALKYLENE OXIDE SULFOSUCCINATES HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) 1984-09-25 US claimed
EP-0103696-A2 Aqueous surfactant concentrates and process for the flow behaviour of viscous aqueous surfactant concentrates Henkel Kommanditgesellschaft auf Aktien (DE) 1984-03-28 EP claimed
US-4379919-A Starch sulfomaleate half-esters, a method for their preparation and their use to prepare starch disulfosuccinate half-esters NATIONAL STARCH AND CHEMICAL CORPORATION (US) 1983-04-12 US claimed
US-3987093-A PROCESS OF PRODUCING CARBOXYDISULFOSUCCINATES CHEVRON RESEARCH COMPANY (US) 1976-10-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260098204-A1 INJECTION FLUIDS COMPRISING AN ANIONIC SURFACTANT FOR TREATING UNCONVENTIONAL FORMATIONS PLA2G10, SOST, BCL2L10 ALDH1A1 3633/4885CYP2D6 2926/4885TSHR 3455/4885
US-20260055314-A1 POLYANIONIC SURFACTANTS AND METHODS OF MAKING AND USING THEREOF LPAR1, CCL11, OR10J3 ALDH1A1 3331/4885CYP2D6 4301/4885TSHR 709/4885
US-12624277-B2 Injection fluids for stimulating fractured formations DEGS1, SCO2, F12 ALDH1A1 4042/4885CYP2D6 3379/4885TSHR 957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.